Health Conditions

Autoimmune Conditions

Other NamesAutoimmune and Autoinflammatory Disease

Natural Remedies10

Ingredients102

Table of contents

Other Names

Autoimmune and Autoinflammatory DiseaseAutoimmune and Autoinflammatory DisorderAutoimmune ConditionAutoimmune DiseaseAutoimmune DiseasesAutoimmune Diseases of the Nervous SystemAutoimmune DisorderAutoimmune DisordersAutoimmune Spectrum DisorderAutoimmunityAutoinflammatory DiseaseAutoinflammatory DisorderAutoreactive DiseaseBreakdown of Self-ToleranceChronic Autoimmune DiseaseChronic Immune-Mediated DiseaseDemyelinating Autoimmune DiseaseImmune DysregulationImmune System DiseaseImmune-Mediated DiseaseImmune-Mediated DiseasesImmune-Mediated DisorderImmune-Mediated Inflammatory DiseaseImmune-Mediated Inflammatory Diseases (IMIDs)Loss of Immune ToleranceOrgan-Specific Autoimmune DiseasePolyautoimmunitySelf-Reactive DiseaseSystemic Autoimmune Disease

Synopsis

Autoimmune Conditions: A Nutrition and Natural Health Reference

1. Definition and Overview

Autoimmunity arises when the immune system fails to distinguish self from non-self at the level of specific regions of cell surface molecules, or epitopes, recognized by two of the major effectors of the immune system: B cells, which produce antibodies, and T cells. Autoimmune disease by definition is autoimmunity that results over time in a pathological outcome, with self-reactive, or autoreactive, T cells and autoantibodies causing tissue damage.

In autoimmune diseases, proteins known as autoantibodies target the body's own healthy tissues by mistake, signaling the body to attack them. Autoimmunity occurs when the body's immune tolerance breaks down and the immune system generates autoreactive antibodies, cells, cytokines, and other molecules that react against components of healthy cells and tissues.

More than 140 known autoimmune diseases have been identified, and symptoms vary extensively based on the organs involved and disease type. Because the immune system traffics into every organ, autoimmune diseases may impact any system in the body and may also affect multiple systems. Many of them are chronic and often debilitating, with no known cures.

1.1 Organ-Specific versus Systemic Disease

Clinically, autoimmune diseases can be restricted in the pattern of organ involvement (organ-specific) or be generalized (systemic or non-organ-specific). Organ-specific examples include Hashimoto's thyroiditis, type 1 diabetes mellitus, and multiple sclerosis. Systemic examples include systemic lupus erythematosus (SLE) and rheumatoid arthritis, which can involve multiple organ systems simultaneously.

Although certain mechanisms unite these conditions into a single category, the clinical manifestations of autoimmune disease are highly varied. These manifestations range from acute, life-threatening organ failure to subtle laboratory abnormalities that can easily escape notice.

1.2 Disease Course and Presentation

Most autoimmune diseases are chronic, but the presentation may be acute. They may be organ- or life-threatening. Symptoms of many autoimmune diseases wax and wane over time. The unpredictability of flares, periods during which symptoms worsen, can be extremely challenging to manage, and although many autoimmune diseases are now treatable, most autoimmune diseases do not have curative interventions.

This dysregulation manifests as chronic inflammation, tissue damage, and systemic dysfunction, with clinical presentations ranging from severe organ failure to subtle biochemical abnormalities. Given their wide-ranging effects on multiple organ systems and the overlap in clinical manifestations, diagnosing autoimmune disorders is inherently challenging. Proper diagnosis requires the identification of disease-specific biomarkers and the performance of tests to rule out other conditions.

1.3 Immune Mechanisms

The immune system has two arms: the more ancient innate immune system and the more recently evolved adaptive immune system. The innate immune system is non-specific to individual pathogens and cannot build memory. Autoimmune pathology can emerge from dysregulation in either or both arms.

T cells with high levels of self-reactivity are removed from the system by two different mechanisms: central tolerance and peripheral tolerance. Central tolerance is associated with the removal of autoreactive T cells during their development in the thymus, while peripheral tolerance is usually controlled by regulatory T cells.

Over the past half century, the science of autoimmunity expanded beyond the concept of autoantibodies and autoreactive T cells, and led to the emergence of the understanding of the importance of the innate immune response against self and other components of inflammation as drivers of autoimmune disease.

2. Prevalence and Epidemiology

Autoimmune diseases are believed to affect 7% to 8% of the U.S. population, between 23.5 and 50.0 million Americans. The global age-standardized prevalence rate of autoimmune diseases nearly doubled from 1990 to 2021.

Autoimmune diseases are a diverse group of conditions characterized by immune disturbances that cause aberrant B cell and T cell reactivity to normal constituents of the host. These diseases can involve essentially any organ system and affect individuals of any age, with a much greater prevalence among women.

Autoimmune diseases are among the leading causes of death among young and middle-aged women in the United States. Incidence rates vary among the autoimmune diseases, with estimates ranging from less than one newly-diagnosed case of systemic sclerosis to more than 20 cases of adult-onset rheumatoid arthritis per 100,000 person-years. At least 85% of thyroiditis, systemic sclerosis, systemic lupus erythematosus, and Sjögren disease patients are female.

Data support a tendency for autoimmune diseases to co-occur at greater than expected rates within proband patients and their families, but this does not appear to be a uniform phenomenon across all diseases.

3. Contributing and Associated Factors

The etiology behind autoimmune diseases is multifactorial, with genetic, hormonal, and environmental factors all playing a role. The pathogenesis of autoimmune diseases is shaped by complex interactions among genetic predisposition, environmental triggers, and epigenetic modifications, which together undermine immune self-tolerance.

3.1 Genetic Factors

Human monozygotic twin studies, animal studies, and genetic models demonstrate that genetic influences strongly determine whether one will develop autoimmunity; however, genes affecting the metabolism of exogenous agents that may trigger disease expression have only recently drawn attention. Genetic factors alone cannot explain this trend; therefore, environmental influences and their interaction with genes must be considered in the pathogenesis of autoimmune diseases.

3.2 Environmental Exposures

Environmental agents have been gaining more attention in recent years for their role in the pathogenesis of autoimmune diseases. Increasing evidence has linked environmental exposures, including trichloroethene (TCE), silica, mercury, pristane, pesticides, and smoking to a higher risk for autoimmune diseases. However, potential mechanisms by which these environmental agents contribute to disease pathogenesis remain largely unknown.

Smoking represents a well-established modifiable risk factor for both MS disease development and progression, while findings regarding alcohol consumption are inconsistent.

3.3 The Gut Microbiome

Dysbiosis of the gut microbiome is an important environmental factor that has been linked to the onset of different autoimmune diseases. Altered microbiota composition is associated with impaired intestinal barrier function and dysregulation of the mucosal immune system, but it is unclear if gut dysbiosis is a causal factor or an outcome of autoimmune diseases.

The gut microbiome, serving as an intermediary between external environmental effectors and the immune system, helps program the immune system to be tolerant to innocent external and self-antigens. However, in the presence of perturbed gut microbiota (dysbiosis), the immune system could be erroneously directed in favor of pro-inflammatory pathways to instigate different autoimmune processes. An accumulating body of evidence, including both experimental and human studies, points to the role of the gut microbiome in different autoimmune diseases.

Chemical-induced gut microbiome dysbiosis can alter intestinal barrier function, mucosal inflammation and immunity, resulting in increased translocation of bacteria, or its metabolites, such as circulating endotoxin lipopolysaccharides (LPS), thus promoting systemic aberrant auto-inflammatory responses, and eventually leading to autoimmune diseases.

Familiar patterns of microbiome dysbiosis have been identified, such as a reduction in microbial diversity, increased intestinal permeability, and the expansion of pro-inflammatory species like Ruminococcus gnavus.

3.4 Sex Hormones

Researchers have reviewed reports that advance understanding of previously recognized environmental risk factors, and challenged accepted beliefs that increased estrogenic exposures predate the incidence of autoimmune disorders, systemic lupus erythematosus in particular. The marked predominance of autoimmune diseases in women — particularly those of reproductive age — points to a role for sex hormones in immune regulation, though the precise mechanisms remain under investigation.

3.5 Obesity

Obesity is characterized by a proinflammatory condition contributing to poor outcomes, but its association with autoimmunity is inconclusive. A systematic review and meta-analysis retrieved over 1,300 records and included 26 studies (8 cross-sectional and 18 longitudinal) to examine the relationship between obesity and autoimmune disease incidence and prevalence.

3.6 Stress and Sleep

Sleep disturbances and chronic stress could influence immune regulation, and may contribute to disease risk and disease course in a subset of patients. Accordingly, while disease-modifying immunotherapy remains the cornerstone of treatment, lifestyle-related factors are increasingly recognized as relevant targets for prevention and supportive disease management.

4. Dietary Factors

4.1 Western Diet as a Risk Factor

Characterized by a high intake of red meat, saturated and trans fats, a low ratio of omega-3:omega-6 fatty acids, and high consumption of refined carbohydrates, the Western diet has been associated with an increased risk of autoimmunity principally through an increase of inflammation and an induction of insulin resistance and obesity.

High salt (sodium chloride) content in the Western diet is implicated via hyperosmotic stress in inflammatory response. Osmotic stress can induce the release of proinflammatory cytokines from human mononuclear cells in culture. Mice on a high-salt diet developed a more severe course of experimental autoimmune encephalomyelitis.

4.2 Protective Dietary Patterns

Lifestyle factors including diet quality and dietary deficiencies potentially contribute to autoimmunity development. The general conclusion from one review was that consumption of a diet rich in vegetables, dietary fibers, and polyunsaturated fatty acids (including fish oils) and low in saturated fat is protective against autoimmunity. This review also cited that deficiencies in vitamin D and folate are common in autoimmune disease.

4.3 Mediterranean Diet

Autoimmune diseases are chronic inflammatory disorders with increasing global prevalence and substantial health and economic burden. The Mediterranean diet (MD), known for its anti-inflammatory and immunomodulatory properties, may offer complementary benefits in the management of these conditions.

The Mediterranean diet has the most evidence as a disease-modifying dietary intervention in autoimmune illnesses. Its protective properties are related to antioxidant and anti-inflammatory effects, which may be related to the abundance of several nutrients, especially dietary fiber, magnesium, omega-3 and mono-unsaturated fatty acids, polyphenols, and tocopherols, that promote a reduction in inflammation as well as insulin resistance.

A 2024 systematic review published in a peer-reviewed journal and conducted according to PRISMA guidelines searched PubMed/MEDLINE, Scopus, Embase, and the Cochrane Library up to February 2024. Anti-inflammatory effects were observed, though evidence remains heterogeneous. Overall certainty of evidence was rated low to moderate using NUTRIGRADE.

The Mediterranean diet's peculiar components, such as n-3 polyunsaturated fatty acids (PUFAs), polyphenols, and fiber, have been explored for their potential benefits in a spectrum of both systemic and organ-specific autoimmune disorders, including rheumatic diseases (like rheumatoid arthritis and systemic lupus erythematosus), and thyroid diseases (like Hashimoto's thyroiditis), since they often occur in the same individuals.

In rheumatoid arthritis, the anti-inflammatory properties of the Mediterranean diet and their impact on disease development and progression have been mixed. Yet, Mediterranean diet consumption has been shown to provide symptomatic improvement, including disease activity, inflammatory markers, and physical function.

5. Nutrients Studied in Relation to Autoimmune Conditions

5.1 Vitamin D

Scientific Evidence: To examine vitamin D and omega-3 fatty acids for the prevention of autoimmune disease, researchers conducted VITAL, a large, nationwide, randomized, double-blind, placebo-controlled trial. The researchers enrolled a total of 25,871 adults aged 50 years or older (for men) and 55 years or older (for women). These participants were first randomized 1:1 to receive either 2,000 IU per day of vitamin D3 or placebo, and then, in a two-by-two factorial design, again randomized 1:1 to either 1 mg per day of n-3 fatty acids or placebo.

Overall, 123 participants in the vitamin D cohort and 155 participants in the corresponding placebo cohort developed a confirmed autoimmune disease during the study period (HR = 0.78; 95% CI 0.61–0.99). This amounted to a 22% reduction in incidence of autoimmune disease according to the researchers.

In the 5.3-year randomized VITAL trial, vitamin D supplementation reduced autoimmune disease incidence (hazard ratio [HR] 0.78, 95% confidence interval [CI] 0.61–0.99). Omega-3 fatty acid supplementation showed a statistically non-significant reduction (HR 0.85, 95% CI 0.67–1.08).

Vitamin D deficiency is a common and clinically relevant finding in inflammatory rheumatic diseases. While supplementation reliably restores adequate levels and may provide modest clinical benefits in deficient patients, current evidence does not support a causal or disease-modifying role across all autoimmune conditions. Meta-analyses show small and inconsistent benefits, limited by heterogeneity in study design, dosing regimens, and populations.

Vitamin D deficiency has been consistently associated with alterations in gut microbiota composition, increased intestinal permeability, impaired immune tolerance, and increased susceptibility to infections and autoimmune conditions; however, evidence from interventional studies remains more variable.

5.2 Omega-3 Polyunsaturated Fatty Acids (PUFAs)

Scientific Evidence: As noted above in the VITAL trial, omega-3 fatty acid supplementation showed a statistically non-significant reduction in autoimmune disease incidence (HR 0.85, 95% CI 0.67–1.08). Results after two additional years of post-intervention observational follow-up were also reported. The evidence for omega-3 PUFAs specifically in autoimmune disease prevention is therefore preliminary and did not reach statistical significance in the primary analysis.

Both animal and human studies present promising findings suggesting a clinical benefit of vitamin D, n-3 PUFA, and green tea catechin EGCG in autoimmune and inflammatory disorders. However, many studies report divergent and discrepant results/conclusions due to various factors.

5.3 Selenium

Traditional Use: Selenium is an essential trace mineral recognized in nutritional medicine for its antioxidant properties, particularly in thyroid physiology. It has been incorporated into dietary practice in regions where soil selenium depletion is common.

Scientific Evidence: Selenium is an essential trace element required for thyroid hormone synthesis and exerts antioxidant effects. Therefore, it may be of relevance in the management of Hashimoto's thyroiditis (HT).

A meta-analysis screened 687 records and included 35 unique studies. The meta-analysis found that selenium supplementation decreased TSH in patients without thyroid hormone replacement therapy (SMD −0.21 [CI −0.43 to −0.02]; 7 cohorts, 869 participants; I² = 0%). In addition, TPOAb (SMD −0.96 [CI −1.36 to −0.56]; 29 cohorts; 2,358 participants; I² = 90%) and malondialdehyde decreased in patients with and without thyroid hormone replacement therapy.

A separate meta-analysis included 21 studies with a total of 1,610 subjects. Serum TPOAb was significantly reduced after selenium supplementation at 3 months (SMD = −0.46, 95% CI: −0.74 to −0.18, P = .001) and 6 months (SMD = −0.80, 95% CI: −1.38 to −0.21, P = .008). Serum TgAb levels decreased at 3 months but not at 6 months.

Evidence strength: Moderate, based on multiple RCTs and meta-analyses with consistent direction of effect for TPO antibody reduction in Hashimoto's thyroiditis, but high heterogeneity (I² up to 90%) limits interpretation, and the clinical significance of antibody reduction alone — separate from thyroid function — remains debated in the literature.

6. Herbs and Botanical Ingredients

6.1 Curcumin (Curcuma longa / Turmeric)

Traditional Use: Curcumin, most commonly consumed as the spice turmeric, is derived from the plant Curcuma longa and is a polyphenolic compound traditionally used in South East Asian and Indian medicine for its anti-inflammatory and antioxidant properties. Curcuma longa has been used as a traditional Chinese medicinal material mainly as turmeric for thousands of years in China.

Scientific Evidence: Systemic autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus represent various autoimmune conditions characterized by immune system dysregulation. The activation of immune cells, auto-antigen outbreak, inflammation, and multi-organ impairment are observed in these disorders.

A number of in vitro and in vivo experiments showed that curcumin has various pharmacological effects such as regulating immunity, anti-oxidation, and inhibiting inflammation. These studies suggest that curcumin may play a regulatory role by altering the activities of enzymes, receptors, and related transcription factors. Numerous randomized controlled trials have shown that curcumin can alleviate many human diseases, including autoimmune diseases, with the main mechanisms involving regulating immunity and inhibiting inflammation.

A systematic review and meta-analysis published in Frontiers in Immunology (2022) analyzed 31 randomized controlled trials across 10 types of autoimmune diseases. Sixteen clinical trials were conducted in osteoarthritis, 14 of which yielded significant improvements in multiple disease parameters. Eight trials were conducted in type 2 diabetes, all yielding significant improvement in clinical or laboratory outcomes. Three trials were in ulcerative colitis, two of which yielded significant improvement in at least one clinical outcome. Additionally, two clinical trials on rheumatoid arthritis, one on lupus nephritis, and two on multiple sclerosis resulted in inconclusive results.

Evidence strength: Preliminary to moderate. Curcumin evidence is strongest for osteoarthritis and inflammatory bowel disease. Evidence in classical autoimmune diseases such as SLE and MS is limited and inconclusive. Bioavailability of standard curcumin is poor, and formulation differences across studies complicate interpretation.

6.2 Boswellia serrata (Indian Frankincense)

Traditional Use: Boswellia has been used for centuries in Ayurvedic medicine for conditions characterized by pain and inflammation, including joint disorders.

Scientific Evidence: Two studies in autoimmune and rheumatic disease trials administered oral Boswellia serrata in conjunction with curcumin supplementation. Boswellia serrata is a gum resin extract which possesses anti-inflammatory and anti-arthritic effects by decreasing glycosaminoglycan levels, which are necessary for cartilage repair.

Patients in one trial were split into two groups, taking either 1,000 mg curcumin-boswellia mixture daily or 200 mg celecoxib daily for 12 weeks. Both treatment groups experienced significant improvement in pain scores, walking distance, joint line tenderness, and crepitus, but there was no significant difference between the two groups. However, the curcumin and boswellia formulation showed greater improvement in pain scores, walking distance, and joint line tenderness in comparison to celecoxib. Treatment was well tolerated without toxicities or adverse effects.

Evidence strength: Preliminary. Studies to date primarily involve osteoarthritis and involve combined formulations, making isolation of Boswellia's independent contribution difficult. Human trial data specifically in autoimmune disease is limited.

6.3 Green Tea / Epigallocatechin-3-Gallate (EGCG)

Traditional Use: Green tea (Camellia sinensis) has been consumed for millennia in East Asian cultures, including traditional Chinese and Japanese medicine, where it was associated with general health promotion and anti-inflammatory effects.

Scientific Evidence: Green tea and its active ingredient, epigallocatechin-3-gallate (EGCG), have been shown to improve symptoms and reduce pathology in some animal models of autoimmune diseases. Whether EGCG's effect is mediated through its impact on Th17 and Treg development has not been fully studied.

Research demonstrated that EGCG inhibited CD4+ T cell expansion in response to either polyclonal or antigen-specific stimulation. EGCG was found to impede Th1 and Th17 differentiation and prevented IL-6-induced inhibition on regulatory T cell (Treg) development. EGCG inhibited Th1 and Th17 differentiation by downregulating their corresponding transcription factors (STAT1 and T-bet for Th1, and STAT3 and RORγt for Th17).

In a murine model of collagen-induced arthritis, EGCG treatment ameliorated clinical symptoms and reduced histological scores in arthritic mice. Serum type-II collagen-specific IgG2a antibodies were significantly lower in EGCG-fed mice compared to PBS-treated mice. EGCG significantly suppressed T cell proliferation and relative frequencies of CD4 T cells, CD8 T cells, and B cell subsets, while increasing the frequency of regulatory T cells (Tregs).

Evidence strength: Largely preclinical (animal and cell models). Human clinical trial data specifically in autoimmune disease settings is limited and has not yet established clinical efficacy. The immunological mechanisms identified in animal models are considered promising but require confirmation in adequately powered human trials.

7. Other Natural Ingredients Discussed in the Literature

7.1 Zinc

Both animal and human studies present promising findings suggesting a clinical benefit of vitamin D, vitamin E, zinc, and probiotics in the reduction of infection and modulation of immune function. Zinc is an essential trace mineral involved in the development and function of immune cells. Deficiency of zinc has been documented in association with immune dysregulation. Human clinical trial evidence specifically targeting autoimmune disease outcomes with zinc supplementation remains preliminary.

7.2 Probiotics

Dietary interventions, fecal microbiota transplantation, and probiotics demonstrated positive effects on clinical outcomes and immune measures across multiple studies. A meta-analysis revealed that microbiota-directed interventions significantly improved disease activity and immune response markers in autoimmune diseases, indicating a robust link between gut microbiota composition and autoimmune pathology.

Meta-analysis findings reveal a consistent reduction in microbial diversity across autoimmune diseases, emphasizing the role of specific taxa and their metabolites in influencing disease severity and immune responses. Therapeutic strategies, such as probiotics, prebiotics, and microbiome-targeted interventions, offer promising avenues to restore microbiome balance and mitigate autoimmune inflammation.

The effects of probiotics cited in the immunological literature are for some specific strains; given the strain-specific nature of the effects of probiotics, these results should not be generalized.

Evidence strength: Growing and mechanistically plausible. The evidence base for probiotics in autoimmune conditions is expanding, but remains heterogeneous due to strain, dose, and disease-specific variation. Larger standardized trials are needed.

8. Dietary and Lifestyle Factors

8.1 Physical Activity

Physical activity exerts immunomodulatory and potential neuroprotective effects through pathways involving cytokines, growth factors, cerebral perfusion, and immune cell redistribution, and is associated with improvements in symptoms, function, and quality of life.

Physically active rheumatoid arthritis patients were found to have a milder disease course, better cardiovascular disease profile, and improved joint mobility. Physical activity decreases fatigue, enhances mood, cognitive abilities, and mobility in patients with multiple sclerosis. In SLE patients, enhanced quality of life and better cardiovascular disease profile were documented in more physically active patients. Physically active patients with type 1 diabetes mellitus have a decreased risk of autonomic neuropathy and cardiovascular disease. Both fibromyalgia and systemic sclerosis patients report decreased disease severity, pain, as well as better quality of life with more physical activity.

8.2 Smoking

Smoking represents a well-established modifiable risk factor for both multiple sclerosis disease development and progression, while findings regarding alcohol consumption are inconsistent. The association between cigarette smoking and autoimmune disease risk has been documented across multiple conditions in the epidemiological literature, with particular strength of evidence for MS and rheumatoid arthritis.

8.3 Sleep and Stress

Sleep disturbances and chronic stress could influence immune regulation and symptom burden, and may act as both risk and disease-modifying factors in autoimmune disease. These associations are supported by mechanistic data suggesting that sleep disruption affects cytokine secretion patterns and neuroendocrine-immune communication pathways, though large interventional trials targeting sleep and stress in autoimmune populations remain limited.

8.4 Gut-Targeted Dietary Interventions

Genetic factors alone cannot explain the rising prevalence of autoimmune diseases; therefore, environmental influences and their interaction with genes must be considered in their pathogenesis. This multifactorial nature suggests that targeting modifiable factors, such as gut health, could help prevent or treat these conditions.

The human microbiome is influenced by genetic, nutritional, and environmental factors, including alterations affected by medications. The impact of diet and environmental exposure, including living environment, hygienic conditions, and oral use of gut health-promoting probiotics, and lifestyle changes, are fundamental influences on the microbiome composition.

References

Natural Remedies

Remedy 1

Anti-Inflammatory / AIP Diet: The Autoimmune Protocol (AIP) diet removes common immune triggers—such as grains, legumes, dairy, processed foods, and refined sugars—while emphasizing nutrient-dense vegetables, clean proteins, and healthy fats. This approach helps reduce flare-ups by eliminating foods that drive inflammation and supporting gut barrier integrity. Gradually reintroduce eliminated foods one at a time to identify personal triggers.

Remedy 2

Turmeric (Curcumin): Turmeric contains curcumin, a compound well-studied for its role in balancing inflammatory pathways and supporting joint and gut health. Add turmeric generously to soups, stews, and golden milk, and pair it with a healthy fat (such as coconut oil) and black pepper to maximize absorption. Curcumin works by inhibiting pro-inflammatory cytokines and enzymes that drive immune overactivity.

Remedy 3

Omega-3 Fatty Acids from Whole Foods: Omega-3s found in fatty fish (salmon, sardines), flaxseed, chia seeds, and walnuts help reduce inflammatory signaling throughout the body. Aim to include fatty fish two to three times per week or add ground flaxseed and walnuts to daily meals. These healthy fats help modulate the immune response and support overall cellular health.

Remedy 4

Probiotic-Rich Fermented Foods: Over 80% of the immune system resides in the gut, and healthy bacteria help train immune cells and maintain gut barrier integrity. Incorporate naturally fermented foods such as sauerkraut, kimchi, kefir (if tolerated), or coconut yogurt regularly into meals. A diverse, well-populated gut microbiome is considered foundational to immune regulation in autoimmune conditions.

Remedy 5

Boswellia (Frankincense): Boswellia serrata resin contains boswellic acids that help interrupt pro-inflammatory mediators and support joint and connective tissue comfort. It has a long history of traditional use and a strong safety profile, and may be taken as a standardized extract in capsule form or as a tea. Boswellia is particularly valued for supporting immune balance without harsh or suppressive effects.

Remedy 6

Adaptogenic Herbs (Ashwagandha & Rhodiola): Adaptogenic herbs such as ashwagandha and rhodiola help the body respond more resiliently to chronic stress, which is a known trigger for autoimmune flare-ups. Ashwagandha helps regulate the stress-hormone response and supports energy balance, while rhodiola supports adrenal function and reduces fatigue. These may be taken as teas, tinctures, or capsules under holistic practitioner guidance.

Remedy 7

Stress Reduction Through Mindfulness & Meditation: Stress activates inflammatory pathways and weakens immune tolerance, making stress management a cornerstone of long-term autoimmune wellness. Daily practices such as mindfulness meditation, breathwork, or gentle yoga help calm the nervous system, lower cortisol levels, and reduce the frequency of flare-ups. Even short daily sessions of 10–15 minutes create measurable benefits over time.

Remedy 8

Prioritizing Quality Sleep: Sleep supports immune repair and regulation, while poor sleep increases inflammatory markers and worsens autoimmune symptoms. Aim for seven to eight hours of quality sleep each night by establishing a consistent bedtime, reducing screen and light exposure in the evening, and creating a cool, dark sleep environment. A regular sleep routine is one of the simplest and most impactful lifestyle tools for immune health.

Remedy 9

Gentle Movement & Exercise: Regular, low-intensity exercise such as walking, swimming, tai chi, or restorative yoga can reduce systemic inflammation and improve overall immune function. It is important to avoid overexertion, as intense exercise can temporarily stress an already reactive immune system; listen to the body and rest during active flare-ups. Gentle daily movement improves circulation, reduces stiffness, supports mood, and helps regulate inflammatory cycles.

Remedy 10

Quercetin-Rich Foods: Quercetin is a flavonoid with potent anti-inflammatory and antihistamine properties, found naturally in apples, onions, blueberries, and capers. Eating a wide variety of these quercetin-rich foods daily helps regulate immune signaling and supports antioxidant defenses in the body. Pairing quercetin sources with bromelain-containing foods like fresh pineapple is thought to boost the compound's absorption and effectiveness.

Ingredients

These ingredients are often used in alternative medicine to support autoimmune conditions.

akkermansia muciniphilaScientific
A. muciniphila has been explored as an immunomodulatory probiotic for autoimmune and chronic inflammatory diseases in experimental models. Metagenomic data show inverse correlations between A. muciniphila abundance and conditions including IBD, type 1 diabetes, and multiple sclerosis. Its outer membrane vesicles suppress pro-inflammatory cytokines and modulate T-cell populations, mechanisms relevant to autoimmune pathogenesis. Human clinical trials specifically for autoimmune diseases are limited.
ALA (alpha-linolenic acid)Scientific
ALA modulates immune function relevant to autoimmune conditions by regulating Th1/Th2/Th17 balance, suppressing pro-inflammatory cytokine production, and influencing T lymphocyte activity. Evidence exists for rheumatoid arthritis and psoriasis as specific autoimmune targets.
ALA (alpha-lipoic acid)Scientific
A 2019 review published in BioMed Research International (PMC6446120) synthesized evidence that ALA exerts immunomodulatory effects on both adaptive and innate immune systems, influencing T cells, B cells, macrophages, and NK cells. ALA modulates NF-κB, suppresses pro-inflammatory cytokines, and has been explored preclinically in models of multiple sclerosis and lupus.
andrographisScientific
Andrographis paniculata and its active constituent andrographolide have demonstrated immunomodulatory effects in experimental autoimmune encephalomyelitis (EAE, a MS model), significantly reducing symptoms by blocking T-cell activation and autoantibody responses to myelin. Traditional use in South and Southeast Asian medicine for inflammatory conditions is well-established.
andrographolideScientific
Andrographolide, the active diterpenoid lactone from Andrographis paniculata, has demonstrated ability to block T-cell activation and significantly reduce experimental autoimmune encephalomyelitis (EAE) symptoms in mice by inhibiting T-cell and antibody responses to myelin antigens. It has established immunomodulatory and anti-inflammatory properties.
artepillin CScientific
Artepillin C is the principal bioactive of Brazilian green propolis with documented immunomodulatory properties including promotion of regulatory T cells, inhibition of Th17 differentiation, and anti-inflammatory NF-κB inhibition. It has been studied in autoimmune-relevant inflammatory models showing significant disease attenuation.
assam indigoScientific
Clinical and pre-clinical studies have demonstrated S. cusia-derived Qingdai's efficacy in autoimmune diseases—specifically psoriasis (multiple RCTs) and ulcerative colitis (multiple clinical trials)—with mechanistic evidence pointing to IL-17 suppression and AHR-Th17/Treg pathway modulation.
astaxanthinScientific
Astaxanthin, a marine carotenoid from Haematococcus pluvialis, has powerful antioxidant and immunomodulatory properties studied in rheumatoid arthritis and multiple autoimmune inflammatory conditions. It reduces pro-inflammatory cytokines, inhibits NF-κB, and modulates T-cell and macrophage activity. Human trials show reductions in inflammatory biomarkers.
astragalusScientific
Astragalus is historically used as an immunomodulator in TCM for immune diseases including nephritis and systemic lupus erythematosus. A 2023 review of 19 studies (1,094 participants) found it enhanced immune responses and reduced proinflammatory cytokines. APS has been studied in adjuvant-induced arthritis and chronic aplastic anemia with positive results in clinical and preclinical settings.
bee propolisScientific
Bee propolis contains CAPE and flavonoids that inhibit NF-κB and reduce pro-inflammatory cytokines relevant to autoimmune inflammation. Clinical and animal studies support anti-inflammatory and immunomodulatory activity in RA and IBD. CAPE promotes Treg cells and suppresses Th17 responses.
black cuminScientific
Clinical trials confirm N. sativa's therapeutic activity in autoimmune-mediated conditions including rheumatoid arthritis, Behcet's disease, and inflammatory bowel disease. The clinical trial review (PMC5633670) explicitly identifies inflammatory and autoimmune disorders as a principal category of established clinical benefit.
black seedScientific
Black seed (Nigella sativa) and its active thymoquinone have demonstrated immunomodulatory and anti-inflammatory effects in multiple autoimmune diseases. Clinical trials in RA and Hashimoto's thyroiditis show reductions in disease activity and inflammatory/autoimmune markers. It modulates T-cell responses, NF-κB, and cytokine production.
borage oilScientific
GLA from borage oil modulates immune responses by acting directly on T lymphocytes and suppressing pro-inflammatory cytokine synthesis (TNF-α, IL-1β, LTB4) in an eicosanoid-independent manner. RA is the best-documented autoimmune application; immunomodulatory effects are supported by mechanistic studies.
boswelliaScientific
Boswellic acids from Boswellia serrata inhibit 5-lipoxygenase, reducing leukotrienes and modulating cytokines relevant to autoimmune inflammation. Pilot clinical studies suggest efficacy in rheumatoid arthritis, Crohn's disease, ulcerative colitis, and multiple sclerosis. Ex vivo research shows Boswellia extracts influence regulatory and effector T-cell compartments.
boswellic acidScientific
Boswellic acids are the active constituents of Boswellia serrata responsible for immunomodulatory and anti-inflammatory actions relevant to autoimmune disease. They inhibit 5-lipoxygenase and modulate cytokines, complement, and T-cell activity. Clinical and preclinical evidence supports benefit in rheumatoid arthritis, ulcerative colitis, and multiple sclerosis models.
bromelainScientific
Bromelain is recommended as an adjuvant therapeutic approach in inflammatory, malignant, and autoimmune diseases. It modulates T cell surface adhesion molecules and TGF-β expression in rheumatoid arthritis and osteomyelofibrosis. Animal studies show efficacy in the experimental allergic encephalomyelitis (EAE) model of multiple sclerosis, and immunomodulatory actions on NK cells and lymphocytes are documented.
bupleurum falcatumScientific
Bupleurum polysaccharides have shown immunomodulatory activity in animal models of autoimmune disease including systemic lupus erythematosus (SLE), improving kidney function, reducing autoantibodies, and delaying lymphadenopathy. Pectic polysaccharides from B. falcatum also demonstrate complement inhibition. Evidence is preclinical.
butyrate triglycerideScientific
Butyrate (including tributyrin-delivered) modulates immune regulatory pathways relevant to autoimmune disease, notably inducing regulatory T cells (Tregs) and reducing pro-inflammatory cytokines via HDAC inhibition. Animal data show sodium butyrate reduces autoimmune hepatitis development. Disrupted intestinal barrier (leaky gut), which butyrate addresses, is linked to autoimmune conditions. Human clinical evidence specifically targeting autoimmune disease with tributyrin is absent.
butyric acidScientific
Butyrate induces regulatory T-cells (Tregs) via HDAC inhibition at the FoxP3 locus and GPR43 activation, suppressing autoimmune-driven inflammation. Evidence spans multiple autoimmune models including type 1 diabetes, IBD, and pancreatitis.
cat's clawScientific
Cat's claw (Uncaria tomentosa) has traditional South American use for arthritis and was studied in a randomized double-blind trial in 40–50 RA patients showing reduced painful joints, morning stiffness, pain intensity, and joint edema vs. placebo. It contains pentacyclic alkaloids and polyphenols with anti-inflammatory and immunomodulatory properties. It decreases IL-6 and NF-κB in preclinical studies.
catalaseScientific
Reduced catalase activity is documented across multiple autoimmune conditions including vitiligo, rheumatoid arthritis, and IBD. Oxidative stress driven by H₂O₂ accumulation is a shared pathogenic mechanism in autoimmune diseases, where catalase deficiency amplifies tissue damage and immune dysregulation.
cod liver oilScientific
Cod liver oil modulates immune responses implicated in multiple autoimmune conditions via EPA and DHA's anti-inflammatory actions and vitamin D's immunoregulatory effects. Observational data link CLO use in infancy with lower type 1 diabetes risk. EPA and DHA are clinically studied in lupus, and vitamin D deficiency is associated with multiple sclerosis and other autoimmune disorders.
coixScientific
Coix seed demonstrates immunomodulatory activity documented across multiple studies. Its polysaccharides and coixol modulate NF-κB, NLRP3, and cytokine pathways relevant to autoimmune regulation. Japanese pharmacopeia approval for warts reflects immunomodulatory clinical recognition.
colostrumScientific
Bovine colostrum contains immunoglobulins (IgG, IgA, IgM), lactoferrin, cytokines, and growth factors that modulate mucosal and systemic immune responses. Clinical evidence supports its use in autoimmune-associated gut permeability ('leaky gut'), inflammatory bowel disease, and immune regulation. It has been studied for its ability to modulate intestinal immune tone.
curcuminScientific
Curcumin, the primary bioactive of turmeric, has been studied in over 30 randomized controlled trials across 10 autoimmune diseases. A 2022 meta-analysis found improvements in ulcerative colitis, rheumatoid arthritis, psoriasis, Crohn's disease, multiple sclerosis, and SLE. It modulates immune cell activity including T cells, B cells, macrophages, and NF-κB signaling.
curcuminoidScientific
Curcuminoids (the family including curcumin, bisdemethoxycurcumin, and demethoxycurcumin) from turmeric collectively exert immunomodulatory and anti-inflammatory effects relevant to autoimmune disease. Clinical evidence from RCTs covers rheumatoid arthritis, ulcerative colitis, SLE, psoriasis, and multiple sclerosis. NF-κB inhibition and cytokine modulation are key mechanisms.
d-alpha tocopherolScientific
Alpha-tocopherol has immunomodulatory properties documented in multiple autoimmune contexts, including RA, MS, and lupus. Its dose-dependent effects on regulatory T cells, dendritic cells, and inflammatory cytokines have been studied in human and animal models, showing modulation of autoimmune pathways without consistent clinical proof of benefit.
DHA (docosahexaenoic acid)Scientific
DHA, a key long-chain omega-3 fatty acid, contributes to anti-inflammatory and immunomodulatory effects in autoimmune diseases alongside EPA. It generates anti-inflammatory resolvins and protectins, and clinical trials in RA and SLE demonstrate benefits. DHA also has evidence for reducing autoimmune flare in animal models.
DHEA (dehydroepiandrosterone)Scientific
Low DHEA levels have been consistently observed in autoimmune diseases including systemic lupus erythematosus (SLE), rheumatoid arthritis, and Sjögren's syndrome. DHEA has been studied most extensively in SLE: a Cochrane review of seven RCTs (n=842) found modest but clinically significant improvement in health-related quality of life and stabilization of disease activity. DHEA possesses anti-inflammatory and immunomodulatory properties.
dihomo-gamma-linolenic acidScientific
DGLA is the direct metabolite of GLA and precursor to anti-inflammatory prostaglandin E1, providing downstream anti-inflammatory effects relevant to autoimmune conditions. Increased tissue DGLA from GLA supplementation has shown benefit in rheumatoid arthritis trials, and DGLA competitively inhibits pro-inflammatory arachidonic acid pathways.
EGCG (epigallocatechin gallate)Scientific
EGCG, the principal catechin in green tea, has been studied in autoimmune conditions including rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and lupus. It inhibits NF-κB, reduces pro-inflammatory cytokines, and suppresses Th17 differentiation. Animal studies show significant disease attenuation in EAE (MS model) and collagen-induced arthritis.
eicosapentaenoic acidScientific
EPA has documented immunomodulatory effects relevant to autoimmune conditions. Epidemiological observations in Inuit populations with high EPA intake noted low rates of autoimmune disorders including psoriasis, asthma, and type-1 diabetes. Multiple RCTs in RA, IBD, and psoriasis demonstrate EPA's capacity to reduce autoimmune-driven inflammation.
EPA (eicosapentaenoic acid)Scientific
EPA is one of the primary active omega-3 fatty acids in fish oil with well-documented effects in rheumatoid arthritis and SLE. Clinical trials show significant reductions in joint tenderness, morning stiffness, and inflammatory biomarkers. EPA competes with arachidonic acid to reduce pro-inflammatory eicosanoid production.
evening primrose oilScientific
Evening primrose oil is a rich source of GLA and has been studied in rheumatoid arthritis trials showing reduction in joint tenderness, swelling, and morning stiffness. It produces anti-inflammatory DGLA and PGE1 by competing with arachidonic acid pathways. Multiple clinical trials support its adjunctive use in RA.
fisetinScientific
Fisetin modulates innate and adaptive immune responses by suppressing NF-κB, TLR4, and inflammasome (NLRP3) pathways, reducing macrophage and neutrophil hyper-activation, and increasing anti-inflammatory IL-10. These mechanisms are preclinically relevant to autoimmune-driven inflammation.
fish oilScientific
Fish oil, providing EPA and DHA, is one of the most studied natural supplements in autoimmune disease. Clinical trials across RA (16/20 showing benefit) and SLE (6/9 showing benefit) support its use as adjunctive therapy. Mechanisms include modulation of eicosanoid synthesis and suppression of pro-inflammatory cytokines.
flaxseedScientific
Flaxseed's ALA omega-3, lignans, and fiber collectively reduce pro-inflammatory cytokine production relevant to autoimmune pathophysiology. A comprehensive review listed autoimmune disorders among conditions where flaxseed oil benefits have been documented across clinical and preclinical studies.
fu lingScientific
Poria cocos bark extracts induced regulatory T cells (Tregs) and showed therapeutic effects in murine atopic dermatitis and food allergy models. Triterpenoid compounds from P. cocos have been used in formulas for rheumatoid arthritis and systemic lupus erythematosus. Immunomodulatory mechanisms involve Th1/Th2 balance modulation and NF-κB inhibition.
fucoidanScientific
Fucoidan, a sulfated polysaccharide from brown algae, modulates immune responses with established immunomodulatory effects relevant to autoimmune conditions. It promotes NK cell activity, modulates T-cell and cytokine responses, and has shown anti-inflammatory effects in RA and IBD animal models and human studies.
fumaric acidScientific
Fumaric acid esters (FAEs), derivatives of fumaric acid, are licensed treatments for psoriasis (an autoimmune skin condition) and the active metabolite dimethyl fumarate (DMF) is FDA- and EMA-approved for relapsing-remitting multiple sclerosis. Clinical studies show reductions in T-lymphocytes, gadolinium-enhancing MRI lesions, and relapse rates in MS.
gentiana macrophyllaScientific
Gentiana macrophylla root has been studied in lupus-prone mouse models (NZB/W F1), demonstrating anti-apoptotic effects on cardiac tissue and attenuation of liver inflammation exacerbated by an autoimmune trigger. TCM documentation of its use in systemic lupus erythematosus (SLE) spans centuries. Immunomodulatory activity is confirmed in pharmacological reviews.
gingerScientific
Ginger and its active constituents (gingerols, shogaols, and zingerone) have anti-inflammatory and immunomodulatory properties studied in rheumatoid arthritis and other autoimmune-related inflammatory conditions. Meta-analyses of RCTs in RA support reductions in pain, stiffness, and inflammatory markers. Ginger inhibits arachidonic acid pathways and NF-κB signaling.
GLA (gamma linolenic acid)Scientific
GLA, an omega-6 PUFA found in borage, evening primrose, and black currant oils, is metabolized to dihomo-gamma-linolenic acid (DGLA), which produces anti-inflammatory eicosanoids. Clinical trials in rheumatoid arthritis have shown reductions in joint tenderness and swelling. It has been studied as adjunctive therapy in multiple autoimmune-mediated inflammatory conditions.
glehnia littoralisScientific
Multiple published studies confirm immunoregulatory properties of G. littoralis extracts. The 2019 PMC systematic review identifies immunoregulatory activity as one of the best-supported pharmacological properties. Traditional use for immune-related diseases is also extensively documented in East Asian medicine.
glycyrrhizinScientific
Glycyrrhizin from licorice root has established immunomodulatory, anti-inflammatory, and corticosteroid-sparing properties studied in autoimmune conditions including SLE, primary biliary cirrhosis (an autoimmune liver disease), and RA. It modulates NF-κB, suppresses excessive immune activation, and has direct anti-inflammatory mechanisms. Traditional Chinese and Ayurvedic use for inflammatory conditions is extensive.
green teaScientific
Green tea and its catechins, particularly EGCG, have demonstrated anti-inflammatory and immunomodulatory effects relevant to autoimmune conditions. Animal studies show significant benefit in MS and RA models; human evidence includes reductions in inflammatory markers. Green tea inhibits NF-κB and suppresses Th17 responses relevant to autoimmunity.
green-lipped musselScientific
Green-lipped mussel (Perna canaliculus) extract contains unique omega-3 fatty acids, glycosaminoglycans, and complex lipids that have been studied in clinical trials for rheumatoid arthritis and osteoarthritis. Studies show reductions in joint pain, stiffness, and swelling. It modulates leukotriene and prostaglandin pathways.
hydrangeaScientific
Halofuginone, a compound derived from Dichroa febrifuga (a plant in the hydrangea family used in Chinese herbal medicine), was shown in a landmark 2009 study in Science to selectively inhibit Th17 cell differentiation in both mouse and human T cells without broadly suppressing immune function. It reduced disease severity in a mouse model of multiple sclerosis. This is the most rigorous mechanistic evidence linking hydrangea-family compounds to autoimmune conditions.
indian frankincenseScientific
Boswellia serrata exhibits immunomodulatory properties documented in preclinical studies, including suppression of pro-inflammatory cytokines, anti-collagen antibodies, and NF-κB in autoimmune arthritis models. Human clinical data in autoimmune-driven colitis (UC as an immune-mediated condition) and RA provides partial clinical support for immunomodulation.
indole-3-carbinolScientific
I3C has been most studied in the context of systemic lupus erythematosus (SLE), both in lupus-prone mouse models and in human ex vivo and pilot clinical studies. In (NZB×NZW)F1 lupus mice, I3C significantly prolonged survival and reduced autoantibodies by inducing tandem B- and T-cell differentiation blockades. Human ex vivo work demonstrated AhR-mediated immunoregulatory effects on SLE macrophages, and a pilot NIH-sponsored clinical trial investigated I3C in women with SLE.
iodineScientific
Iodine intake has a well-documented bidirectional relationship with autoimmune thyroid diseases (AITD), principally Hashimoto's thyroiditis and Graves' disease. Excessive iodine intake is an established environmental trigger for AITD in genetically susceptible individuals. Conversely, iodine deficiency also alters thyroid immunogenicity. AITD represents the most prevalent organ-specific autoimmune diseases, affecting 2–5% of the population.
lactobacillus caseiScientific
L. casei 01 has demonstrated clinical benefit in rheumatoid arthritis—an autoimmune joint disease—in a double-blind RCT, reducing disease activity scores and inflammatory cytokines. Broader preclinical evidence shows L. casei modulates Th1/Th17/Treg immune balance relevant to autoimmunity. The anti-inflammatory cytokine IL-10 was specifically increased by L. casei in the RA trial.
lactobacillus rhamnosusScientific
L. rhamnosus modulates immune tolerance mechanisms relevant to autoimmune pathology, including Th17/Treg balance, intestinal barrier integrity, and IL-10 production. LGG has been studied in IBD—a prototypic autoimmune-related condition—and shown to reduce colonic inflammation via the STING pathway. It has also been studied in celiac disease models, rescuing BDNF disruption caused by gliadin.
lactococcus lactisScientific
GM L. lactis has been engineered to deliver autoantigens (e.g., human insulin) and anti-inflammatory cytokines mucosally to induce tolerance in autoimmune conditions, including autoimmune type 1 diabetes. A Frontiers in Immunology review documents L. lactis as a versatile vehicle for tolerogenic immunotherapy with completed human clinical trials in mucosal pathologies, and preclinical data supporting autoimmune diabetes reversal.
lactoferrinScientific
Lactoferrin, an iron-binding glycoprotein from colostrum and milk, modulates innate and adaptive immune responses and has anti-inflammatory properties relevant to autoimmune disease. It regulates cytokine production, promotes Treg cells, and reduces pro-inflammatory NF-κB signaling. Evidence includes studies in RA and IBD.
licorice rootScientific
Licorice root (Glycyrrhiza) contains glycyrrhizin and glabridin with immunomodulatory and anti-inflammatory properties relevant to autoimmune disease. Intravenous glycyrrhizin is used clinically in Japan for autoimmune liver disease. Traditional Chinese and Ayurvedic medicine use licorice extensively in formulas for autoimmune inflammatory conditions.
luteolinScientific
Luteolin, a dietary flavone found in vegetables and herbs, has documented anti-inflammatory and immunomodulatory properties studied in autoimmune diseases including RA, MS, IBD, and SLE. It inhibits NF-κB, suppresses Th17 differentiation, and promotes Treg cells. Animal studies demonstrate significant attenuation of EAE and collagen-induced arthritis.
maitake mushroomScientific
Maitake's beta-glucan D-fraction is an immunomodulator that activates macrophages, NK cells, and T-cells. A Phase II clinical trial in myelodysplastic syndrome patients showed maitake extract enhanced neutrophil and monocyte function. The immunomodulatory action is bidirectional, potentially relevant to autoimmune contexts, though no dedicated autoimmune human RCTs exist.
mannoseScientific
D-mannose has demonstrated immunosuppressive effects in multiple animal models of autoimmune disease, and its mechanism—promotion of regulatory T cell (Treg) differentiation via TGF-β activation—has been confirmed in vitro in human cells. No human RCTs for autoimmune conditions have been completed. Evidence is mechanistic and preclinical, with human in vitro corroboration.
melatoninScientific
Melatonin has immunomodulatory properties and has been studied in autoimmune diseases including SLE, RA, and multiple sclerosis. It modulates Th17/Treg balance, reduces oxidative stress, and exhibits anti-inflammatory effects. Clinical data show lower melatonin levels in SLE patients, and supplementation trials demonstrate reductions in disease activity markers.
myristoleateScientific
The Siemandi 1997 RCT explicitly included autoimmune arthritis patients and concluded CMO appeared to provide relief to autoimmune inflammatory diseases, potentially long-term. CMO's proposed immune-modulating mechanism — involving modulation of cytokine signaling via N-myristoylation pathways — provides a plausible mechanistic basis for benefit in autoimmune conditions. Evidence is limited to arthritis-spectrum autoimmune disease.
N-acetyl-glucosamineScientific
NAG modulates T-cell and B-cell function through the hexosamine biosynthetic pathway and N-glycan branching, suppressing pathological autoimmune responses. A 2023 mechanistic clinical trial (Journal of Neuroinflammation, UCI) in multiple sclerosis patients found NAG reduced neuroinflammation and neurodegeneration markers and improved neurological function in 30% of participants.
NAC (N-acetyl cysteine)Scientific
NAC is a glutathione precursor with antioxidant and immunomodulatory properties that has been clinically studied in SLE, RA, and multiple sclerosis. In a randomized pilot trial in SLE, NAC supplementation reduced disease activity (SLEDAI) and fatigue scores. It corrects glutathione deficiency common in autoimmune diseases and modulates mTOR signaling in T cells.
omega-3 fatty acidsScientific
Omega-3 fatty acids (EPA and DHA) have been extensively studied in autoimmune diseases, with 20 clinical trials in rheumatoid arthritis (16 showing significant benefit) and 9 trials in SLE/lupus nephritis (6 showing improvement). They modulate eicosanoid synthesis toward anti-inflammatory profiles and suppress pro-inflammatory cytokines.
omega-6 fatty acidsScientific
Omega-6 PUFAs, particularly GLA and its metabolite DGLA, modulate T-cell-mediated immune responses in autoimmune disease. In experimental autoimmune models, omega-6-enriched (GLA-rich) diets reduced disease severity through TGF-β1 upregulation and altered eicosanoid production. Human evidence focuses on specific conditions (RA, MS, atopic dermatitis) with mixed but partially positive results for GLA-rich supplementation.
PABA (para-aminobenzoic acid)Scientific
PABA holds FDA approval for dermatomyositis and has been used clinically in scleroderma, lupus erythematosus, and morphea—all autoimmune conditions. Its proposed mechanism includes modulation of fibroblast activity and, as shown in in vitro studies, induction of endogenous interferon, which plays a central role in autoimmune pathophysiology. Results across these conditions are mixed and evidence is mostly from older, small, or uncontrolled studies.
peonyScientific
TGP from Paeonia lactiflora is a registered Chinese medicine drug for autoimmune diseases including rheumatoid arthritis, systemic lupus erythematosus (SLE), Sjögren's syndrome, and ankylosing spondylitis. Multiple systematic reviews and meta-analyses support its immunomodulatory efficacy in reducing disease activity across these conditions.
PEP (prolyl endopeptidase)Scientific
Celiac disease is a systemic autoimmune disorder triggered by gliadin peptides that activate CD4+ T cells in HLA-DQ2/DQ8-positive individuals, causing autoantibody production against tissue transglutaminase. PEP enzymes target and destroy these T-cell epitopes, and multiple phase I/II human clinical trials have tested PEP-based oral enzyme therapies as adjuncts to the gluten-free diet in celiac disease.
phlebodium decumanumScientific
Phlebodium decumanum is a tropical fern whose extract (marketed as Kalawalla/Calagualine) has been clinically studied for autoimmune conditions including psoriasis and multiple sclerosis. It modulates T-cell activity and reduces autoimmune skin and neurological manifestations. Clinical trials show reductions in psoriasis plaques and MS relapse.
propionic acidScientific
Propionate has been most extensively studied as an immunomodulatory SCFA in multiple sclerosis (MS), where serum propionate levels are reduced in newly diagnosed patients relative to healthy controls. Clinical studies of propionate supplementation in MS patients show expansion of regulatory T cells and reduced pro-inflammatory Th1/Th17 responses, with reported long-term clinical improvements. Research also implicates propionate deficiency in gut dysbiosis-driven systemic immune dysregulation across autoimmune diseases.
propolisScientific
Bee propolis and its bioactive compounds (artepillin C, caffeic acid phenethyl ester/CAPE, flavonoids) have demonstrated immunomodulatory effects in autoimmune conditions including RA and IBD. CAPE inhibits NF-κB and reduces pro-inflammatory cytokines. Clinical and preclinical evidence supports anti-inflammatory and immune-balancing effects.
quercetinScientific
Quercetin, a dietary flavonoid, has been shown to attenuate rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, and systemic lupus erythematosus in human and animal studies. It exerts anti-inflammatory, antioxidant, and neuroprotective actions. A 2021 review in Frontiers in Immunology summarized its pharmacological applications across multiple autoimmune diseases.
rehmanniaScientific
Rehmannia has documented immunomodulatory activity in multiple autoimmune disease models. A 2017 Taiwanese retrospective cohort study showed decreased lupus nephritis risk in SLE patients using Rehmannia. Catalpol modulates Th17/Treg balance in RA models, and acteoside re-regulates B-cell IL-10 production in autoimmune settings. Rehmannia is prescribed in classical TCM formulas for lupus (Zhi Bai Di Huang Wan) and Sjögren's syndrome.
reishi mushroomScientific
Reishi exerts immune-modulatory effects, shifting Th1/Th2/Treg balance and suppressing excessive inflammatory signalling relevant to autoimmune pathology. Preclinical research shows promise in rheumatoid arthritis and Sjögren's syndrome models. Life Extension cites laboratory studies demonstrating reishi's promise in autoimmune disease. TCM used reishi extensively for conditions resembling autoimmune presentations.
resveratrolScientific
Resveratrol, a stilbenoid polyphenol from grapes and berries, has demonstrated immunomodulatory and anti-inflammatory properties in autoimmune disease models and clinical trials. It inhibits NF-κB, promotes Treg cells, and suppresses Th17 responses. Human RCTs in SLE patients have shown reductions in disease activity and inflammatory biomarkers.
rosmarinic acidScientific
Rosmarinic acid modulates autoreactive T-cell activity by inducing apoptosis of activated T cells (demonstrated directly in cells from rheumatoid arthritis patients), inhibiting complement activation, and suppressing pro-inflammatory cytokine production from immune cells. These actions are mechanistically relevant across autoimmune diseases including RA, lupus-related glomerulonephritis, and atopic conditions.
sarsaparillaScientific
Smilax glabra's astilbin has demonstrated immunosuppressive activity on Th17 cell differentiation and T-lymphocyte activation in peer-reviewed studies, mechanisms central to multiple autoimmune diseases. The immunomodulatory classification of sarsaparilla by MSKCC reflects this evidence. No human autoimmune disease trials have been conducted.
seleniumScientific
Selenium has the strongest single-supplement evidence for Hashimoto's autoimmune thyroiditis. A 2024 meta-analysis of 35 RCTs found consistent TPO antibody reductions of 20–40% over 6+ months. Selenium maintains glutathione peroxidase activity, supports T-regulatory cell function, and deficiency correlates with higher autoimmune incidence.
selenomethionineScientific
Selenomethionine is the most extensively studied form of selenium for autoimmune thyroiditis (Hashimoto's disease). Multiple RCTs and meta-analyses confirm it significantly reduces serum thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb). A 2024 meta-analysis of 21 RCTs (n=1,610) found selenomethionine more effective than sodium selenite or selenium yeast for this indication. Clinical relevance for disease progression outcomes remains under investigation.
silymarinScientific
Silymarin's immunomodulatory effects—suppression of NF-κB, TNF-α, and T-cell-mediated inflammation—have led to investigation in autoimmune contexts. Documented uses include rheumatoid arthritis and lupus considerations in dermatological and pharmacological literature. Evidence is preliminary and largely mechanistic; controlled human RCTs for specific autoimmune diseases are very limited.
smilaxScientific
Astilbin from Smilax glabra has been specifically studied as an immunomodulatory agent in autoimmune conditions including collagen-induced arthritis and psoriasis-like models. A 2003 US patent was awarded for smilax flavonoids in treating autoimmune diseases and inflammatory reactions. The mechanism involves selective T-cell modulation rather than broad immune suppression.
SPMs (specialized pro-resolving mediators)Scientific
SPMs modulate adaptive immune cell function (T cells, B cells, dendritic cells) to promote resolution without immunosuppression. Chronic autoimmune disorders are characterized by SPM deficiency and resolution failure. SPMs have demonstrated utility in preclinical autoimmune models and are being evaluated for human autoimmune conditions.
sulforaphaneScientific
Sulforaphane, an isothiocyanate from cruciferous vegetables, activates the Nrf2/antioxidant response pathway and inhibits NF-κB, producing anti-inflammatory and immunomodulatory effects studied in multiple sclerosis, RA, and IBD. Animal studies show significant disease attenuation in EAE and CIA models; human pilot data show reductions in inflammatory markers.
sweet wormwoodScientific
Artemisinins from A. annua have documented immunosuppressive effects studied in SLE, rheumatoid arthritis, and IBD in both clinical and animal settings. Dihydroartemisinin is being evaluated in Chinese clinical trials for SLE. Published reviews confirm multi-pathway immune modulation.
tetrahydro iso-alpha acidsScientific
THIAA inhibits BTK, Syk, and PI3K isoforms — kinases central to B-cell receptor signaling implicated in autoimmune pathogenesis. In a collagen-induced RA model (an established autoimmune disease model), THIAA reduced arthritis index and joint degradation dose-dependently. These kinase targets overlap with those of approved autoimmune therapeutics.
thymoquinoneScientific
Thymoquinone is the primary bioactive of Nigella sativa (black seed) with well-documented anti-inflammatory and immunomodulatory effects in autoimmune disease models. It inhibits NF-κB, suppresses Th1/Th17 cytokines, and promotes regulatory T cells. Preclinical studies demonstrate benefit in EAE, CIA, and IBD; clinical evidence derives from N. sativa supplementation trials.
trans-geranylgeraniolScientific
GGOH/GGPP deficiency directly causes an autoinflammatory disease — mevalonate kinase deficiency (MKD/HIDS) — through impaired protein prenylation and consequent inflammasome hyperactivation. A 2024 pilot study in three HIDS patients found GG supplementation improved inflammatory parameters and reversed the disease-specific protein signature. This establishes GGOH as having a documented, mechanistic link to a specific autoinflammatory (immune-dysregulation) condition.
turmericScientific
Turmeric (Curcuma longa) and its curcumin extracts have been studied in 31 RCTs across 10 autoimmune diseases, with demonstrated improvements in rheumatoid arthritis, ulcerative colitis, psoriasis, Crohn's disease, SLE, and multiple sclerosis. It modulates immune cells and key inflammatory pathways including NF-κB. Traditional Ayurvedic use for arthritis and inflammatory bowel conditions spans millennia.
tylophoraScientific
Tylophora alkaloids have been shown in experimental models to inhibit cellular immune responses, suppress T-cell proliferation, reduce delayed-type hypersensitivity reactions, and modulate IL-2 production — mechanisms directly relevant to autoimmune pathology. These immunomodulatory effects are documented in peer-reviewed studies and represent the most mechanistically distinct scientific contribution of Tylophora.
uncariaScientific
Uncaria tomentosa (cat's claw) has a randomized double-blind clinical trial in RA showing reduction in painful joints, morning stiffness, pain intensity, and joint edema versus placebo. It contains immunomodulatory alkaloids and polyphenols that modulate T-cell balance and reduce NF-κB and IL-6. Traditional Amazonian use for inflammatory and rheumatic conditions is well-established.
vitamin DScientific
Vitamin D has robust scientific evidence as an immunomodulator relevant to autoimmune disease prevention and management. The VITAL trial showed 2000 IU/day reduced new autoimmune disease incidence by 22% over 5 years. Clinical trials have been conducted in MS, RA, Crohn's disease, type 1 diabetes, and SLE. Vitamin D regulates T-regulatory cells, suppresses T-cell proliferation, and modulates macrophage function.
vitamin D3Scientific
Vitamin D3 (cholecalciferol) specifically is the form most studied and used in autoimmune disease prevention and treatment. The VITAL trial used 2000 IU/day D3, reducing new autoimmune disease incidence by 22%. It regulates T-regulatory cells, suppresses adaptive immune overactivation, and VDR-mediated signaling is relevant across MS, RA, T1D, and SLE.
adrenal cortexTraditional
Adrenal cortex extract has been used traditionally for autoimmune conditions, grounded in cortisol's immunomodulatory and immunosuppressive functions. Contemporary alternative practitioners recommend it for autoimmune diseases as an adjunct. No clinical trial evidence supports OTC adrenal cortex supplements for autoimmune conditions.
ashwagandhaTraditional
Ashwagandha has traditional Ayurvedic use in conditions resembling autoimmune diseases, and preclinical data shows reduction of autoreactive T cells and inflammatory cytokines in animal models of RA and lupus. However, clinical evidence in human autoimmune populations is limited. Its immunostimulant effects also create theoretical risk of aggravating certain autoimmune diseases.
bovine spleenTraditional
Spleen extracts, and tuftsin in particular, have been studied in animal autoimmune disease models including experimental autoimmune encephalomyelitis. Traditionally, spleen was given for autoimmune-related immune dysregulation. Evidence is restricted to preclinical studies; no human clinical data support bovine spleen supplementation for autoimmune conditions.
echinacea purpureaTraditional
Traditional contraindication listings from the German Commission E, WHO, and ESCOP caution against E. purpurea use in autoimmune diseases such as multiple sclerosis, lupus, and collagen disorders, based on theoretical immune stimulation concerns. More recent pharmacological evidence suggests lipophilic alkamide-containing preparations may instead suppress cellular immunity, complicating the picture.
ganodermaTraditional
Ganoderma lucidum is documented in traditional Asian medicine for autoimmune-related conditions including autoimmune hepatitis and arthritis. Preclinical evidence shows it modulates T-cell and B-cell responses, regulates cytokine production, and has complement-inhibitory properties relevant to autoimmune pathology.
indian tinosporaTraditional
Indian tinospora (Tinospora cordifolia) has deep traditional Ayurvedic use as an immunomodulator for rheumatic and inflammatory autoimmune conditions. It modulates macrophage, NK cell, and lymphocyte activity. Preclinical studies confirm anti-inflammatory and immunoregulatory effects; clinical RCT data in specific autoimmune diseases remain limited.
rehmannia glutinosaTraditional
Rehmannia is one of the few Chinese herbs specifically used for autoimmune diseases including lupus, rheumatoid arthritis, and Sjögren's syndrome. It appears in classical formulas prescribed for these conditions and is combined with Astragalus for immune balance. Immunomodulatory mechanisms are documented preclinically.
skullcapTraditional
S. baicalensis has documented immunomodulatory effects: it shifts Th1/Th2 balance, suppresses IgE production and allergic immune responses, and modulates NF-κB-driven inflammation relevant to autoimmunity. TCM uses Huang Qin for inflammatory and immune-mediated conditions. Clinical trials in specific autoimmune diseases are limited.
tinospora cordifoliaTraditional
Tinospora cordifolia (guduchi/giloy) has extensive traditional Ayurvedic use as an immunomodulator for autoimmune and inflammatory conditions. It contains alkaloids, diterpenoids, and polysaccharides that modulate macrophage and lymphocyte activity. Preclinical studies support anti-inflammatory and immunoregulatory effects, though robust clinical trials in specific autoimmune diseases are limited.
whole adrenal glandularTraditional
Adrenal glandular extract is listed in naturopathic and integrative medicine traditions as supportive for autoimmune conditions, on the basis that adrenal cortical hormones (glucocorticoids) are potent immune modulators. The EBSCO Research Starters monograph lists autoimmune disorders as a proposed use. Modern products lack meaningful glucocorticoid content, and no clinical trials support this application.